2014
DOI: 10.1097/fjc.0000000000000061
|View full text |Cite
|
Sign up to set email alerts
|

Il-15

Abstract: Cardiovascular disease is the leading cause of death in Western countries. A major limitation of current treatments is the inability to efficiently repair or replace dead myocardium. Recently, stem cell based therapies have been explored as an avenue to circumvent current therapeutic limitations. Overall, these therapies appear to result in small improvements in the contractile function of the heart. The exact mechanism(s) of action that underlie these improvements remain unknown and it is believed that paracr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 22 publications
(5 citation statements)
references
References 28 publications
0
5
0
Order By: Relevance
“…6c ). The hearts of exercise-trained Atg7 h&mKO mice also had markedly reduced levels of the PPARGC1α target Fndc5 33 and the pro-survival Il15 34 (Supplementary Fig. S3c ).…”
Section: Resultsmentioning
confidence: 99%
“…6c ). The hearts of exercise-trained Atg7 h&mKO mice also had markedly reduced levels of the PPARGC1α target Fndc5 33 and the pro-survival Il15 34 (Supplementary Fig. S3c ).…”
Section: Resultsmentioning
confidence: 99%
“…For example, the expression level of Il15 in adult cluster A3 was found to be decreased at P7 in the Sox6 KO heart (Table 4). It has been recently demonstrated that Il15 protects cardiomyocytes from oxidative stress [114], suggesting that Il15 could be involved in protection from oxidative stress during postnatal heart development, and Sox6 could be a positive regulator of Il15 in the early postnatal heart. Lyz1 in adult cluster A4 was also differentially expressed at two time points (decreased at P7 and P30) in the Sox6 KO heart (Table 4).…”
Section: Resultsmentioning
confidence: 99%
“…IL-15 is pleiotropic proinflammatory cytokine with structural similarity with IL-2, which predominantly exerts anabolic and tissue protective effects by decreasing cardiac myocyte apoptosis, mobilization of endothelial and mesenchymal progenitor cells, reduction of oxidative stress, and improvement of myocardial function [ 149 ]. On hypoxia condition, cardiac myocytes express appropriate IL-15 receptor, by which IL-15 protects the myocardium against injury [ 149 ]. IL-15 activates signaling by the β and common γ ( γ c) chain heterodimer of the IL-2 receptor and thereby supports survival and proliferation of natural killer cells and suppresses oxidative stress [ 150 ].…”
Section: Myokines In Hf Myopathymentioning
confidence: 99%